Genomics and world peace

September 10, 2002

The authors warn that we must no longer view the diseases of the developing world in purely medical or public health contexts. Infectious diseases could pose a major risk to the economic survival of many developing nations. Even more striking, recent data suggest that some of these diseases may have wider implications for geopolitical stability or the probability that a nation will experience armed conflict. "If it is possible to transfer weapon technology to the developing world it should be possible to transfer innovative countertechnologies to these countries. We believe that genomics could be such a countertechnology," says Samuel Broder.

The progress resulting from genomic research is significant. It has already advanced our knowledge of infectious diseases. The complete genomic sequences of many pathogens responsible for morbidity and mortality in the developing world are now established. The new tools in comparative genomics, computational biology, and informatics have already yielded promising results in studying invertebrate parasites that cause tropical diseases. When combined with the sequence of the human genome, and the sequence of some of the vectors of disease, like the Anopheles mosquitoes that transmit malaria parasites, they offer remarkable opportunities for reducing the negative impact of these diseases.

However, the authors point out that the applications of this research might only benefit patients in the First World, since there has been little or no commercial interest in developing treatments against the tropical diseases that occur among the world's poorest people. The authors illustrate this with several diseases such as malaria, hookworm and AIDS. "To achieve greater impact for the developing countries it will be necessary to combine the efforts made by some not-for-profit organisations and private funds to support research for the developing world and to link genomic research with vaccine research and other technologies." says Samuel Broder. "It will also be necessary to transfer these new technologies to developing countries and to give these countries access to necessary information, such as gene data bases."
-end-
For interviews & further questions contact

Samuel Broder
Celera Genomics
Rockville, MD, USA
Sam.Broder@celera.com

Stephen L. Hoffman
Sanaria
308 Argosy Drive
Gaithersburg, MD 20878
slhoffman@sanaria.com

Peter J Hotez
Dept. Microbiology and Tropical Medicine
The George Washington University
Ross Hall,
Washington
mtmpjh@gwumc.edu

To obtain a PDF of the full length article or photos of the authors please contact
Ellen Peerenboom
EMBO Press & Public Relations Officer
Postfach 102240
D69012 Heidelberg
Tel: 0049 6221 8891 108
Fax: 0049 6221 8891 200
ellen.peerenboom@embo.org

the authors
Samuel Broder
is vice president of medical affairs at Celera Genomics of Rockville, MD, an Applera Corporation
business. He can be reached at sam.broder@celera.com

Stephen L. Hoffman
past president of the American Society of Tropical Medicine and Hygiene, is at Sanaria, Gaithersburg, MD
slhoffman@sanaria.com

Peter J. Hotez
is Professor and Chair of the Department of Microbiology and Tropical Medicine at the George Washington University in Washington, DC and senior fellow and chairman of the Scientific Advisory Council of the Sabin Vaccine Institute, Rockville, MD, USA
mtmpjh@gwumc.edu

for authors photos see http://www.embo.org/press/reports/september.html and contact ellen.peerenboom@embo.org for better quality photos

full reference
Broder et al. (2002) Cures for the Third World's problems. EMBO reports vol. 3(9). 806-812

the journal
EMBO reports is more than just a scientific journal. It publishes a variety of sharply focused short papers, key reviews and meeting reports from all areas of molecular biology, thus keeping a broad readership abreast of the latest primary research. Its Science & Society section discusses the impact that politics, society and the financial world have on the environment in which the sciences are performed and visa versa are interesting for a broader audience.

European Molecular Biology Laboratory

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.